|
 |
Dilworth JR, Lewis JS, Miller JR, Zheng Y. The preparation of rhenium (V) oxo- and imido- complexes with Et2NCSNCOPh and Et2NCSNC(NH)Ph. The crystal and molecular structure of [ReOCl(PhCONCSEt2)2]. Polyhedron 12:221-225, 1993.
Dilworth JR, Lewis JS, Miller JR, Zheng Y. Rhenium complex of a triply deprotonated chelated thiosemicarbazide and its conversion to a nitride complex via a hydrazide intermediate. Crystal structure of [ReCI2(NH)(NHNH2)(PPh3)2]. Journal of the Chemical Society, Dalton Transactions, 1357-1361, 1995.
Dilworth JR, Hutson AJ, Lewis JS, Miller JR, Zheng Y, Chen Q, Zubieta J. Complexes of potentially tri- and tetradentate phosphinothiol ligands with Mo, W, Re, Fe, Ru, Os, Rh, Ir and Ni. The crystal and molecular structures of [Me4N]2[Mo(CO)3{PhP(C6H4-2S)2}], [Re{PhP(C6H4-2S)2}2] and [IrH(CO){PhP(C6H4-2S)2}(PPh3)]. Journal of the Chemical Society, Dalton Transactions, 1093-1104, 1996.
Lewis JS, Zweit J, Dearling JLJ, Rooney BC, Blower PJ. Copper(I)bisphosphine complexes as a basis for radiopharmaceuticals for positron emission tomography and targeted radiotherapy. Chemical Communications, 1093-1094, 1996.
Lewis JS, Heath SL, Powell AK, Zweit J, Blower PJ. Diphosphine bifunctional chelators for low-valent metal ions. Crystal structures of the copper(I) complexes [CuClL12] and [CuL12][PF6] [L1 = 2,3-bis(diphenylphosphino)maleic anhydride]. J Chem Soc, Dalton Trans, 855-863, 1997.
Lewis JS, Zweit J, Blower PJ. Effect of ligand and solvent on chloride ion coordination in anti-tumour copper(I) diphosphine complexes: synthesis of [Cu(dppe)2]Cl and analogous complexes (dppe = 1,2-bis(diphenylphosphino)ethane). Polyhedron 17:513-517, 1998.
Anderson CJ, Jones LA, Bass LA, Sherman ELC, McCarthy DW, Cutler PD, Lanahan MV, Cristel ME, Lewis JS, Schwarz SW. Radiotherapy, toxicity and dosimetry of copper-64-labeled-TETA-octreotide in tumor bearing rats. Journal of Nuclear Medicine 39:1944-1951, 1998.
Dearling JLJ, Lewis JS, McCarthy DW, Welch MJ, Blower PJ. Redox-active metal complexes for imaging hypoxic tissues: structure-activity relationships in copper(II) bis(thiosemicarbazone) complexes. Chemical Communications 22:2531-2533, 1998.
Dearling JLJ, Mullen GED, Lewis JS, Rae MR, Zweit J, Welch MJ and Blower PJ. Hypoxia-Selective Copper-64 Complexes. In: Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine 5, Eds: M. Nicolini and U. Mazzi, 599-605, 1999.
Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Anderson CJ. Structure-activity studies of Cu-64-labeled somatostatin analogs for diagnostic imaging and targeted radiotherapy. In: Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine 5, Eds: M. Nicolini and U. Mazzi, 53-59, 1999.
Reichert DE, Lewis JS, Anderson CJ. Metal Complexes as Diagnostic Tools. Coordination Chemistry Reviews 184:3-66, 1999.
Anderson CJ, Lewis JS. Radiopharmaceuticals for targeted radiotherapy of cancer. Expert Opinion on Therapeutic Patents 10(7): 1057-1069, 2000.
Chao KSC, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity modulated radiation therapy. International Journal of Radiation Oncology, Biology, and Physics, 49(2):1171-1182, 2001.
Obata A, Yoshimi E, Waki A, Lewis JS, Oyama N, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis(N4-methylthiosemicarbazone)(Cu-ATSM) in tumor cells. Annals of Nuclear Medicine, 15(6):499-504, 2001.
Lewis JS, Herrero P, Sharp TL, Engelbach JA, Fujibayashi Y, Laforest R, Kovacs A, Gropler RJ, Welch MJ. Delineation of Hypoxia in Canine Myocardium using PET and Copper-diacetyl-bis(N4-methylthiosemicarbazone). Journal of Nuclear Medicine, 43:1557-1569, 2002.
Vavere A. L., Lewis JS and Welch MJ. Imaging of Antiangiogenic Treatments: Ti-45-transferrin MicroPET as a Surrogate Marker for Tumor Response. In: Technetium, Rhenium and other Metals in Chemistry and Nuclear Medicine 6, Eds: M. Nicolini and U. Mazzi, 101-105, 2002.
Lewis JS and Welch MJ. Copper chemistry related to radiopharmaceutical production. In: Technetium, Rhenium and other Metals in Chemistry and Nuclear Medicine 6, Eds: M. Nicolini and U. Mazzi, 23-33, 2002.
Zalutsky MR, Lewis JS. Radiolabeled antibodies for tumor imaging and therapy, In Handbook of Radiopharmaceuticals: Radiochemistry and Applications. Eds: M. J. Welch and C. S. Redvanly 685-714, 2002.
Obata A, Yoshimoto M, Kasamatsu S, Naiki H, Takamatsu S, Kashikura K, Furukawa T, Lewis JS, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Intra-tumoral distribution of 64Cu-ATSM: A comparison study with FDG. Nuclear Medicine and Biology 30:529-534, 2003.
Mathias CJ, Lewis MR, Reichert DE, Laforest R, Sharp TL, Lewis JS, Yang Z-F, Waters DJ, Snyder PW,Low PS, Welch MJ and Green MA. Preparation of 66Ga- and 68Ga-labeled Ga(III)-Deferoxamine-Folate as Potential Folate-Receptor-Targeted PET Radiopharmaceuticals. Nuclear Medicine and Biology, 30:725-731, 2003.
Obato A, Kasmatsu S, Lewis JS, Furukawa T, Takamatsu S, Toyahara J, Asai T, Welch MJ, Adams SG, Saji H, Yonekura Y, Fujibayashi Y. Basic characterization of 64Cu-ATSM as a radiotherapy agent. Nuclear Medicine and Biology, 32:21-28, 2005.
O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL. Assessment of Regional Tumor Hypoxia using 18F-FMISO and 64Cu-ATSM Positron Emission Tomography: A Comparative Study featuring MicroPET Imaging, pO2 Probe Measurement, Autoradiography and Fluorescent Microscopy in the R3327-AT and FaDu Rat Tumor Models. International Journal of Radiation Oncology, Biology, and Physics, 61(5): 1493-1502, 2005.
Parry R, Schneider D, Hudson D, Parkes D, Xuan J-A, Newton A, Toy P, Lin R, Harkins R, Alicke B, Biroc S, Kretschmer PJ, Halks-Miller M, Klocker H, Zhu Y, Larsen B, Cobb RR, Bringmann P, Roth G, Lewis JS, Dinter H, Parry G. Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate Cancer. Cancer Research 65, 8397-8405, 2005.
Laforest R, Sharp TL, Engelbach JA, Fettig NM, Herrero P, Kim J, Lewis JS, Rowland DJ, Tai Y-C, Welch MJ. Measurement of Input Functions in Rodents: Challenges and Solutions. Nuclear Medicine and Biology 32: 679-685, 2005.
Welch MJ, Laforest R, Lewis JS. Production of Non-Standard PET Radionuclides and the Application of Radiopharmaceuticals Labeled with these Nuclides, in PET Chemistry: The Driving Force in Molecular Imaging Series: Ernst Schering Research Foundation Workshop, Vol. 62. Schubiger, P. August; Lehmann, Lutz; Friebe, Matthias (Eds.), XII, 159-182, 2007.
Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KSC, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D. Hypoxia: Importance in Tumor Biology, Noninvasive Measurement by Imaging, and Value of its Measurement in the Management of Cancer Therapy. (Proceedings of an NIC workshop "Hypoxia: Importance in Tumor Biology, Noninvasive Measurement by Imaging, and Value of its Measurement in the Management of Cancer Therapy," April 5-6, 2004, in Phoenix). International Journal of Radiation Biology, 82, 699-757, 2006.
Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS. Synthesis and Biological Eva67. Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS. Synthesis and Biological Evaluation of Cu-64 labeled Rhenium-Cyclized á-MSH Peptide Analog Using a Cross-Bridged Cyclam Chelator. Journal of Nuclear Medicine 48: 64-72, 2007.luation of Cu-64 labeled Rhenium-Cyclized á-MSH Peptide Analog Using a Cross-Bridged Cyclam Chelator. Journal of Nuclear Medicine 48: 64-72, 2007.
Jost SC, Wanebo JE, Song SK, Chicoine MR, Rich KM, Woolsey TA, Lewis JS, Mach RH, Xu J, Garbow JR. In Vivo Imaging in a Murine Model of Glioblastoma, Neurosurgery, 60, 360-370, 2007.
Biddlecombe GB, Rogers BE, de Visser M, Parry JJ, de Jong M, Erion JL, Lewis JS. Molecular Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors in Mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-Bombesin(1-14). Bioconjugate Chemistry, 18, 724-730, 2007.
Lewis JS, Anderson CJ. Radiometal-labeled somatostatin analogues for applications in cancer imaging and therapy. In Peptide Characterization and Application Protocols (Methods in Molecular Biology, 386), G.B. Fields (Ed), Humana Press, ISBN 1-588-29550-8, Chapter 8, 227-240, 2007.
Alidori S, Gioia Lobbia G, Papini G, Pellei M, Porchia M, Refosco F, Tisato F, Lewis JS, Santini C. Synthesis, in vitro and in vivo characterization of 64Cu(I)-complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands. Journal of Biological Inorganic Chemistry, 13:307-315, 2008.
Dietz D W, Dehdashti FD, Grigsby PW, Malyapa RS, Myerson RJ, Picus J, Ritter J, Lewis JS, Welch M J, Siegel B A. Tumor hypoxia detected by Positron Emission Tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. Diseases of the Colon & Rectum, 51; 1641-1648, 2008.
|
|
|
|
